M
Mega Lifesciences PCL
SET:MEGA
Mega Lifesciences PCL
SET:MEGA
Price:
39.5
THB
1.28%
Market Cap:
฿34.4B
Relative Value
The Relative Value of one MEGA stock under the Base Case scenario is 36.43 THB. Compared to the current market price of 39.5 THB, Mega Lifesciences PCL is Overvalued by 8%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
MEGA
Relative Value
Base Case
36.43
THB
Overvaluation 8%
M
Multiples Across Competitors
MEGA Competitors Multiples
Mega Lifesciences PCL Competitors
Mega Lifesciences PCL Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| TH |
M
|
Mega Lifesciences PCL
SET:MEGA
|
34.4B THB | 2.4 | 17.4 | 9.4 | 10.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
982.7B USD | 15.1 | 47.6 | 32.1 | 34.1 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
586.1B USD | 6.2 | 21.9 | 15.2 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
294.5B CHF | 4.8 | 31.3 | 13.2 | 15.4 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
243B GBP | 5.6 | 32.4 | 17.8 | 25.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
247.9B CHF | 5.7 | 22.8 | 14 | 18 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
302.6B USD | 4.7 | 16.6 | 10.3 | 12.1 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.4 | 13.4 | 9.8 | 11.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.1B USD | 2.5 | 20.1 | 7.5 | 10 | |
| UK |
|
GSK plc
XETRA:GS71
|
105.8B EUR | 2.8 | 16.1 | 8.1 | 11.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
